David Han serves as Chairman of the NOVA Chemicals Audit, Risk & Compliance Committee.
He joined One Equity Partners in 2005 and is a Senior Managing Director and a member of the Investment Committee, the Operating Committee and the Valuation Committee. David led One Equity Partners’ investments in Celltrion Healthcare, Columbian Chemicals, OCI, ORS Medco, PeroxyChem, Pirelli Tyre, and Sonneborn. He is a member of the Board of Directors of ORS Medco and previously served as Chairman of PeroxyChem and on the Boards of Celltrion Healthcare, Columbian Chemicals, OCI, Pirelli Tyre and Sonneborn.
Prior to joining OEP, David spent 18 years as a Mergers and Acquisitions banker. He began his investment banking career as an Associate at Lehman Brothers and was a Vice President at Morgan Stanley, a Managing Director at Smith Barney, a Managing Director at Greenhill, and a Managing Director at Credit Suisse. He received his MBA from Harvard Business School and his BA in Economics from Cornell University.